Advanced search
Publication Cover
Future Microbiology Volume 5, 2010 - Issue 5
Submit an article Journal homepage
612
Views
0
CrossRef citations to date
0
Altmetric
Review

Role of Secretory Immunoglobulin a and Secretory Component in the Protection of Mucosal Surfaces

Blaise CorthésyR&D Laboratory of the Department of Immunology & Allergy, University State Hospital (CHUV), Rue du Bugnon 46, 1011Lausanne, Switzerland. [email protected]View further author information
Pages 817-829 | Published online: 05 May 2010

Bibliography

  • Nagler-Anderson C : Man the barrier! Strategic defences in the intestinal mucosa.Nat. Rev. Immunol.1(1) , 59–67 (2001).
  • Brandtzaeg P : Induction of secretory immunity and memory at mucosal surfaces.Vaccine25(30) , 5467–5484 (2007).
  • Mestecky J , MoroI, KerrMA, WoofJ: Mucosal immunoglobulins. In: Mucosal Immunology. Mestecky, J, Lamm ME, Strober W, Bienenstock J, McGhee JR, Mayer LL (Eds). Elsevier/Academic Press, Amsterdam, The Netherlands, 153–181 (2005).
  • Phalipon A , CorthésyB: Novel functions for mucosal SIgA of IgA. In: Mucosal immune defense: immunoglobulin A. Kaetzel CS (Ed.). Springer, NY, USA, 183–202 (2007).
  • Macpherson AJ , McCoyKD, JohansenFE, BrandtzaegP: The immune geography of IgA induction and function.Mucosal Immunol.1(1) , 11–22 (2008).
  • Kaetzel CS : The polymeric immunoglobulin receptor: bridging innate and adaptive immune responses at mucosal surfaces.Immunol. Rev.206 , 83–99 (2005).
  • Russell MW , KilianM: Biological activities of IgA. In: Mucosal Immunology. Mestecky, J, Lamm ME, Strober W, Bienenstock J, McGhee JR, Mayer LL (Eds). Elsevier/Academic Press, Amsterdam, The Netherlands, 267–290 (2005).
  • Mach J , HshiehT, HsiehD, GrubbsN, ChervonskyA: Development of intestinal M cells.Immunol. Rev.206 , 177–189 (2005).
  • Hase K , KawanoK, NochiTet al.: Uptake through glycoprotein 2 of FimH(+) bacteria by M cells initiates mucosal immune response.Nature462(7270) , 226–230 (2009).
  • Favre L , SpertiniF, CorthésyB: Secretory IgA possesses intrinsic modulatory properties stimulating mucosal and systemic immune responses.J. Immunol.175(5) , 2793–2800 (2005).
  • Fagarasan S , HonjoT: Regulation of IgA synthesis at mucosal surfaces.Curr. Opin. Immunol.16(3) , 277–283 (2004).
  • He B , XuW, SantiniPAet al.: Intestinal bacteria trigger T cell-independent immunoglobulin A(2) class switching by inducing epithelial-cell secretion of the cytokine APRIL.Immunity26(6) , 812–826 (2007).
  • Tsuji M , KomatsuN, KawamotoSet al.: Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyer‘s patches.Science323(5920) , 1488–1492 (2009).
  • Corthésy B : Roundtrip ticket for secretory IgA: role in mucosal homeostasis?J. Immunol.178(1) , 27–32 (2007).
  • Kilian M , MesteckyJ, RussellMW: Defense mechanisms involving Fc-dependent functions of immunoglobulin A and their subversion by bacterial immunoglobulin A proteases.Microbiol. Rev.52(2) , 296–303 (1988).
  • Chintalacharuvu KR , RainesM, MorrisonSL: Divergence of human α-chain constant region gene sequences. A novel recombinant α 2 gene.J. Immunol.152(11) , 5299–5304 (1994).
  • Chintalacharuvu KR , MorrisonSL: Residues critical for H-L disulfide bond formation in human IgA1 and IgA2.J. Immunol.157(8) , 3443–3449 (1996).
  • Grey HM , AbelCA, YountWJ, KunkelHG: A subclass of human γ-A-globulins (γ-A2) which lacks the disulfied bonds linking heavy and light chains.J. Exp. Med.128(6) , 1223–1236 (1968).
  • Koshland ME : The coming of age of the immunoglobulin J chain.Annu. Rev. Immunol.3 , 425–453 (1985).
  • Johansen FE , BraathenR, BrandtzaegP: Role of J chain in secretory immunoglobulin formation.Scand. J. Immunol.52(3) , 240–248 (2000).
  • Hexham JM , WhiteKD, CarayannopoulosLNet al.: A human immunoglobulin (Ig)A ca3 domain motif directs polymeric Ig receptor-mediated secretion.J. Exp. Med.189(4) , 747–752 (1999).
  • Frütiger S , HughesGJ, PaquetN, LüthiR, JatonJC: Disulfide bond assignement in human J chain and its covalent pairing with immunoglobulin M.Biochemistry31(50) , 12643–12647 (1992).
  • Hendrickson BA , ConnerDA, LaddDJet al.: Altered hepatic transport of immunoglobulin A in mice lacking the J chain.J. Exp. Med.182(6) , 1905–1911 (1995).
  • Hendrickson BA , RindisbacherL, CorthésyBet al.: Lack of association of secretory component with IgA in J chain-deficient mice.J. Immunol.157(2) , 750–754 (1996).
  • Eiffert H , QuentinE, WiederholdMet al.: Determination of the molecular structure of the human free secretory component.Prot. Chem. Hoppe-Seyler372(2) , 119–128 (1991).
  • Frütiger S , HughesGJ, FonckC, JatonJC: High and low molecular weight rabbit secretory components. Evidence for the deletion of the second and third domains in the smaller polypeptide.J. Biol. Chem.262(4) , 1712–1715 (1987).
  • Bakos MA , KuroskyA, GoldblumRM: Characterization of a critical binding site for human polymeric Ig on secretory component.J. Immunol.147(10) , 3419–3426 (1991).
  • Fallgreen-Gebauer E , GebauerW, BastianAet al.: The covalent linkage of SC to IgA: structure of secretory IgA.Biol. Chem. Hoppe-Seyler374(11) , 1023–1028 (1993).
  • Hughes GJ , FrütigerS, SavoyLA, ReasonAJ, MorrisHR, JatonJC: Human free secretory component is composed of the first 585 amino acid residues of the polymeric immunoglobulin receptor.FEBS Lett.410(2–3) , 443–446 (1997).
  • Lindh E , BjörkI: Binding of secretory component to dimers of immunoglobulin A in vitro. Mechanism of the covalent bond formation.Eur. J. Biochem.62(2) , 263–270 (1976).
  • Rindisbacher L , CottetS, WittekR, KraehenbuhlJP, Corthésy,B: Production of human secretory component with dimeric IgA binding capacity using viral expression systems.J. Biol. Chem.270(23) , 14220–14228 (1995).
  • Crottet P , CorthésyB: Mapping the interaction between murine IgA and murine secretory component carrying epitope substitutions reveals a role of domains II and III in covalent binding to IgA.J. Biol. Chem.274(44) , 31456–31462 (1999).
  • Endo T , MesteckyJ, KulhavyR, KobataA: Carbohydrate heterogeneity of human myeloma proteins of the IgA1 and IgA2 subclasses.Mol. Immunol.31(18) , 1415–1422 (1994).
  • Mattu TS , PleassRJ, WillisACet al.: The glycosylation and structure of human serum IgA1, Fab, and Fc regions and the role of N-glycosylation on Fc α receptor interactions.J. Biol. Chem.273(4) , 2260–2272 (1998).
  • Royle L , RoosA, HarveyDJet al.: Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems.J. Biol. Chem.278(22) , 20140–20153 (2003).
  • Roque-Barreira MC , Campos-NetoA: Jacalin: an IgA-binding lectin.J. Immunol.134(3) , 1740–1743 (1985).
  • Arnold JN , WormaldMR, SimRB, RuddPM, DwekRA: The impact of glycosylation on the biological function and structure of human immunoglobulins.Annu. Rev. Immunol.25 , 21–50 (2007).
  • Taylor AK , WallR: Selective removal of a heavy-chain glycosylation sites causes immunoglobulin A degradation and reduced secretion.Mol. Cell. Biol.8 , 4197–4203 (1988).
  • Baenziger JU : Structure of the oligosaccharide of human J chain. Structure of the oligosaccharide of human J chain.J. Biol. Chem.254(10) , 4063–4071 (1979).
  • Hughes GJ , ReasonAJ, SavoyL, JatonJ, Frutiger-HughesS: Carbohydrate moieties in human secretory component.Biochim. Biophys. Acta1434(1) , 86–93 (1999).
  • Perrier C , SprengerN, CorthésyB: Glycans on secretory component participate in innate protection against mucosal pathogens.J. Biol. Chem.281(20) , 14280–14287 (2006).
  • Bonner A , AlmogrenA, FurtadoPB, KerrMA, PerkinsSJ: The nonplanar secretory IgA2 and near planar secretory IgA1 solution structures rationalize their different mucosal immune responses.J. Biol. Chem.284(8) , 5077–5087 (2009).
  • Bonner A , AlmogrenA, FurtadoPB, KerrMA, PerkinsSJ: Location of secretory component on the Fc edge of dimeric IgA1 reveals insight into the role of secretory IgA1 in mucosal immunity.Mucosal Immunol.2(1) , 74–84 (2009).
  • Bloth B , SvehagSE: Further studies on the ultrastructure of dimeric IgA of human origin.J. Exp. Med.133(5) , 1035–1042 (1971).
  • Brandtzaeg P , PrydzH: Direct evidence for an integrated function of J chain and secretory component in epithelial transport of immunoglobulins.Nature311(5981) , 71–73 (1974).
  • Johansen FE , BraathenR, BrandtzaegP: The J chain is essential for polymeric Ig receptor-mediated epithelial transport of IgA.J. Immunol.167(9) , 5185–5192 (2001).
  • Bonner A , PerrierC, CorthésyB, PerkinsSJ: Solution structure of human secretory component and implications for biological function.J. Biol. Chem.282(23) , 16969–16980 (2007).
  • Ladjeva I , PetermanJH, MesteckyJ: IgA subclasses of human colostral antibodies specific for microbial and food antigens.Clin. Exp. Immunol.78(1) , 85–90 (1989).
  • Angel J , FrancoMA, GreenbergHB: Rotavirus vaccines: recent developments and future considerations.Nat. Rev. Microbiol.5(7) , 529–539 (2007).
  • Burns JW , Siadat-PajouhM, KrishnaneyAA, GreenbergHB: Protective effect of rotavirus VP6-specific IgA monoclonal antibodies that lack neutralizing activity.Science72(5258) , 104–107 (1996).
  • Corthésy B , BenureauY, PerrierCet al.: Rotavirus anti-VP6 secretory immunoglobulin A contributes to protection via intracellular neutralization but not via immune exclusion.J. Virol.80(21) , 10692–10699 (2006).
  • O‘Neal CM , HarrimanGR, ConnerME: Protection of the villus epithelial cells of the small intestine from rotavirus infection does not require immunoglobulin A.J. Virol.74(9) , 4102–4109 (2000).
  • Franco MA , AngelJ, GreenbergHB: Immunity and correlates of protection for rotavirus vaccines.Vaccine24(15) , 2718–2731 (2006).
  • Suerbaum S , MichettiP: Helicobacter pylori infection.N. Engl. J. Med.347(15) , 1175–1186 (2002).
  • Malfertheiner P , ChanFK, McCollKE: Peptic ulcer disease.Lancet374(9699) , 1449–1461 (2009).
  • Covacci A , RappuoliR: Helicobacter pylori: after the genome, back to biology.J. Exp. Med.197(7) , 807–811 (2003).
  • Prinz C , HafsiN, VolandP: Helicobacter pylori virulence factors and the host immune response: implications for therapeutic vaccination.Trends Microbiol.11(3) , 134–138 (2003).
  • Del Giudice G , MalfertheinerP, RappuoliR: Development of vaccines against Helicobacter pylori.Expert Rev. Vaccines8(8) , 1037–1049 (2009).
  • Blanchard TG , CzinnSJ, MaurerR, ThomasWD, SomanG, NedrudJG: Urease-specific monoclonal antibodies prevent Helicobacter felis infection in mice.Infect. Immun.63(4) , 1394–1399 (1995).
  • Ahlstedt I , LindholmC, LönrothH, HamletA, SvennerholmAM, Quiding-JärbrinkM: Role of local cytokines in increased gastric expression of the secretory component in Helicobacter pylori infection.Infect. Immun.67(9) , 4921–4925 (1999).
  • Goto T , NishizonoA, FujiokaT, IkewakiJ, MifuneK, NasuM: Local secretory immunoglobulin A and postimmunization gastritis correlate with protection against Helicobacter pyloriinfection after oral vaccination of mice.Infect. Immun.67(5) , 2531–2539 (1999).
  • Ferrero RL , ThibergeJM, LabigneA: Local immunoglobulin G antibodies in the stomach may contribute to immunity against Helicobacter infection in mice.Gastroenterology113(1) , 185–194 (1997).
  • Casswall TH , NilssonHO, BjörckLet al.: Bovine anti-Helicobacter pylori antibodies for oral immunotherapy.Scand. J. Gastroenterol.37(12) , 1380–1385 (2002).
  • Kelly CP , PothoulakisC, LaMontJT: Clostridium difficile colitis.N. Engl. J. Med.330(4) , 257–262 (1994).
  • Lyerly DM , KrivanHC, WilkinsTD: Clostridium difficile: its disease and toxins.Clin. Microbiol. Rev.1(1) , 1–18 (1988).
  • Stubbe H , BerdozJ, KraehenbuhlJP, CorthésyB: Polymeric IgA is superior to monomeric IgA and IgG carrying the same variable domain in preventing Clostridium difficile toxin A damaging of T84 monolayers.J. Immunol.164(4) , 1952–1960 (2000).
  • Cottet S , Corthésy-TheulazI, SpertiniF, CorthésyB: Microaerophilic conditions permit to mimic in vitro events occurring during in vivoHelicobacter pylori infection and to identify Rho/Ras-associated proteins in cellular signaling.J. Biol. Chem.277(37) , 33978–33986 (2002).
  • Renegar KB , SmallPA: Passive transfer of local immunity to influenza-virus infection by IgA antibody.J. Immunol.146(6) , 1972–1978 (1991).
  • Renegar KB , SmallPA: Immunoglobulin A mediation of murine nasal anti-influenza virus immunity.J. Virol.65(4) , 2146–2148 (1991).
  • Takase H , MurakamiY, EndoA, IkeuchiT: Antibody responses and protection in mice immunized orally against influenza virus.Vaccine14(17–18) , 1651–1656 (1996).
  • Tamura S , FunatoH, HirabayashiYet al.: Cross-protection against influenza-A virus-infection by passively transferred respiratory-tract IgA antibodies to different hemagglutinin molecules.Eur. J. Immunol.21(6) , 1337–1344 (1991).
  • Mazanec MB , CoudretCL, FletcherDR: Intracellular neutralization of influenza virus by immunoglobulin A anti-hemagglutinin monoclonal antibodies.J. Virol.69(2) , 1339–1343 (1995).
  • Fujioka H , EmancipatorSN, AikawaMet al.: Immunocytochemical colocalization of specific immunoglobulin A with sendai virus protein in infected polarized epithelium.J. Exp. Med.188(7) , 1223–1229 (1998).
  • Kozlowski PA , NeutraMR: The role of mucosal immunity in prevention of HIV transmission.Curr. Mol. Med.3(3) , 217–228 (2003).
  • Bomsel M , HeymanM, HociniHet al.: Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM.Immunity9(2) , 277–287 (1998).
  • Huang YT , WrightA, GaoX, KulickL, YanH, LammME: Intraepithelial cell neutralization of HIV-1 replication by IgA.J. Immunol.174(8) , 4828–4835 (2005).
  • Jackson S , MesteckyJ, MoldoveanuZ, SpearmanP: Collection and processing of human mucosal secretions. In: Mucosal Immunology. Ogra PL, Mestecky, J, Lamm ME, Strober W, Bienenstock J, McGhee JR (Eds). Academic Press, CA, USA, 1567–1575 (1999).
  • Wright A , LammME, HuangYT: Excretion of human immunodeficiency virus type 1 through polarized epithelium by immunoglobulin A.J. Virol.82(23) , 11526–11535 (2008).
  • Devito C , BrolidenK, KaulRet al.: Mucosal and plasma IgA from HIV-1-exposed uninfected individuals inhibit HIV-1 transcytosis across human epithelial cells.J. Immunol.165(9) , 5170–5176 (2000).
  • Moja P , TranchatC, TchouIet al.: Neutralization of human immunodeficiency virus type 1 (HIV-1) mediated by parotid IgA of HIV-1-infected patients.J. Infect. Dis.181(5) , 1607–1613 (2000).
  • Alfsen A , IniguezP, BouguyonE, BomselM: Secretory IgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1.J. Immunol.166(10) , 6257–6265 (2001).
  • Mantis NJ , PalaiaJ, HessellAJet al.: Inhibition of HIV-1 infectivity and epithelial cell transfer by human monoclonal IgG and IgA antibodies carrying the b12 V region.J. Immunol.179(5) , 3144–3152 (2007).
  • Xu W , SantiniPA, SullivanJSet al.: HIV-1 evades virus-specific IgG2 and IgA responses by targeting systemic and intestinal B cells via long-range intercellular conduits.Nat. Immunol.10(9) , 1008–1017 (2009).
  • Kaetzel CS , RobinsonJK, ChintalacharuvuKR, VaermanJP, LammME: The polymeric immunoglobulin receptor (secretory component) mediates transport of immune complexes across epithelial cells: a local defense function for IgA.Proc. Natl Acad. Sci. USA88(19) , 8796–8800 (1991).
  • Robinson JK , BlanchardTG, LevineAD, EmancipatorSN, LammME: A mucosal IgA-mediated excretory immune system in vivo.J. Immunol.166(6) , 3688–3692 (2001).
  • Kramer DR , CebraJJ: Early appearance of “natural” mucosal IgA responses and germinal centers in suckling mice developing in the absence of maternal antibodies.J. Immunol.154(5) , 2051–2062 (1995).
  • van der Waaij LA , LimburgPC, MesanderG, van der Waaij D: In vivo IgA coating of anaerobic bacteria in human faeces. Gut38(3) , 348–354 (1996).
  • Bos NA , JiangHQ, CebraJJ: T-cell control of the gut IgA response against commensal bacteria.Gut48(6) , 762–764 (2001).
  • Macpherson AJ , GattoD, SainsburyE, HarrimanGR, HengartnerH, ZinkernagelRM: A primitive T cell-independent mechanism of intestinal mucosal IgA responses to commensal bacteria.Science288(5474) , 2222–2226 (2000).
  • Shroff KE , MeslinK, CebraJJ: Commensal enteric bacteria engender a self-limiting humoral mucosal immune response while permanently colonizing the gut.Infect. Immun.63(10) , 3904–3913 (1995).
  • Cebra JJ : Influences of microbiota on intestinal immune system development.Am. J. Clin. Nutr.69(5) , S1046–S1051 (1999).
  • Macpherson AJ , UhrT: Induction of protective IgA by intestinal dendritic cells carrying commensal bacteria.Science303(5664) , 1662–1665 (2004).
  • Kadaoui KA , CorthésyB: Secretory IgA mediates bacterial translocation to dendritic cells in mouse Peyer‘s patches with restriction to mucosal compartment.J. Immunol.179(11) , 7751–7757 (2007).
  • Macpherson AJ , GeukingMB, McCoyKD: Immune responses that adapt the intestinal mucosa to commensal intestinal bacteria.Immunology115(2) , 153–162 (2005).
  • Harris NL , SpoerriI, SchopferJFet al.: Mechanisms of neonatal mucosal antibody protection.J. Immunol.177(9) , 6256–6262 (2006).
  • Fagarasan S , MuramatsuM, SuzukiK, NagaokaH, HiaiH, HonjoT: Critical roles of activation-induced cytidine deaminase in the homeostasis of gut flora.Science298(5597) , 1424–1427 (2002).
  • Biesbrock AR , ReddyMS, LevineMJ: Interaction of a salivary mucin-secretory immunoglobulin A complex with mucosal pathogens.Infect. Immun.59(10) , 3492–3497 (1991).
  • Phalipon A , CorthésyB: Novel functions of the polymeric Ig receptor: well beyond transport of immunoglobulins.Trends Immunol.24(2) , 55–58 (2003).
  • Bollinger RR , EverettML, PalestrantD, LoveSD, LinSS, ParkerW: Human secretory immunoglobulin A may contribute to biofilm formation in the gut.Immunology109(4) , 580–587 (2003).
  • Macpherson AJ , SlackE: The functional interactions of commensal bacteria with intestinal secretory IgA.Curr. Opin. Gastroenterol.23(6) , 673–678 (2007).
  • Mowat AM : Anatomical basis of tolerance and immunity to intestinal antigens.Nat. Rev. Immunol.3(4) , 331–341 (2003).
  • Mestecky J , RussellMW, ElsonCO: Perspectives on mucosal vaccines: is mucosal tolerance a barrier?J. Immunol.179(9) , 5633–5638 (2007).
  • Freytag LC , ClementsJD: Mucosal adjuvants.Vaccine23(15) , 1804–1813 (2005).
  • Schubert C : Boosting our best shot.Nat. Med.15(9) , 984–988 (2009).
  • Zinkernagel RM : Maternal antibodies, childhood infections, and autoimmune diseases.N. Engl. J. Med.345(18) , 1331–1335 (2001).
  • Newburg DS , WalkerWA: Protection of the neonate by the innate immune system of developing gut and of human milk.Pediatr. Res.61(1) , 2–8 (2007).
  • Casswall TH , SarkerSA, FaruqueSMet al.: Treatment of enterotoxigenic and enteropathogenic Escherichia coli-induced diarrhoea in children with bovine immunoglobulin milk concentrate from hyperimmunized cows: a double-blind, placebo-controlled, clinical trial.Scand. J. Gastroenterol.35(7) , 711–718 (2000).
  • Houdebine LM : Production of pharmaceutical proteins by transgenic animals.Comp. Immunol. Microbiol. Infect. Dis.32(2) , 107–121 (2009).
  • Kamihira M , KawabeY, ShindoTet al.: Production of chimeric monoclonal antibodies by genetically manipulated chickens.J. Biotechnol.141(1–2) , 18–25 (2009).
  • Corthésy B : Recombinant secretory immunoglobulin A in passive immunotherapy: linking immunology and biotechnology.Curr. Pharm. Biotechnol.17(2) , 198–203 (2003).
  • Casadevall A , DadachovaE, PirofskiLA: Passive antibody therapy for infectious diseases.Nat. Rev. Microbiol.2(9) , 695–703 (2004).
  • Starlinger M , SchiesselR: Bicarbonate (HCO3) delivery to the gastroduodenal mucosa by the blood: its importance for mucosal integrity.Gut29(5) , 647–654 (1988).
  • Mohamed AH , HuntRH: The rationale of acid suppression in the treatment of acid-related disease.Aliment. Pharmacol. Ther.8(Suppl. 1) , 3–10 (1994).
  • Kaye RS , PurewalTS, AlparOH: Development and testing of particulate formulations for the nasal delivery of antibodies.J. Control Release135(2) , 127–135 (2009).
  • Corthésy B : Recombinant immunoglobulin A: powerful tools for fundamental and applied research.Trends Biotechnol.20(2) , 65–71 (2002).
  • Phalipon A , KaufmannM, MichettiPet al.: Monoclonal immunoglobulin A antibody directed against serotype-specific epitope of Shigella flexnerilipopolysaccharide protects against murine experimental shigellosis.J. Exp. Med.182(3) , 769–778 (1995).
  • Weltzin R , Traina-DorgeV, SoikeKet al.: Intranasal monoclonal IgA antibody to respiratory syncytial virus protects Rhesus monkeys against upper and lower respiratory tract infection.J. Infect. Dis.174(8) , 256–261 (1996).
  • Ma JK , HykmatBY, WycoffKet al.: Characterization of a recombinant plant monoclonal secretory antibody and preventive immunotherapy in humans.Nat. Med.4(5) , 601–606 (1998).
  • Enriquez FJ , RiggsMW: Role of immunoglobulin A monoclonal antibodies against P23 in controlling murine Cryptosporidium parvum infection.Infect. Immun.66(9) , 4469–4473 (1998).
  • Phalipon A , CardonaA, KraehenbuhlJP, EdelmanL, SansonettiPJ, CorthésyB: Secretory component: a new role in secretory IgA-mediated immune exclusion in vivo.Immunity17(1) , 107–115 (2002).
  • Hutchings AB , HelanderA, SilveyKJet al.: Secretory immunoglobulin A antibodies against the sigma1 outer capsid protein of reovirus type 1 Lang prevent infection of mouse Peyer‘s patches.J. Virol.78(2) , 947–957 (2004).
  • Williams A , ReljicR, NaylorIet al.: Passive protection with immunoglobulin A antibodies against tuberculous early infection of the lungs.Immunology111(3) , 328–333 (2004).
  • Yankov ID , PetrovDP, MladenovIVet al.: Protective efficacy of IgA monoclonal antibodies to O and H antigens in a mouse model of intranasal challenge with Salmonella enterica serotype enteritidis.Microbes Infect.6(10) , 901–910 (2004).
  • Gorrell RJ , Robins-BrowneRM: Antibody-mediated protection against infection with Helicobacter pylori in a suckling mouse model of passive immunity.Infect. Immun.77(11) , 5116–5129 (2009).
  • Halpern M , KoshlandME: The stoichiometry of J chain in human secretory IgA.J. Immunol.111(6) , 1653–1660 (1973).
  • Crottet P , CorthésyB: Secretory component delays the conversion of secretory IgA into antigen-binding competent F(ab´)2: a possible implication for mucosal defense.J. Immunol.161(10) , 5445–5453 (1998).
  • Boullier S , TanguyM, KadaouiKet al.: Secretory IgA-mediated neutralization of Shigella flexneri prevents intestinal tissue destruction by down-regulating inflammatory circuits.J. Immunol.183(9) , 5879–5885 (2009).
  • Wold AE , MesteckyJ, TomanaMet al.: Secretory immunoglobulin A carries oligosaccharide receptors for Escherichia coli type 1 fimbrial lectin.Infect. Immun.58(9) , 3073–3077 (1990).
  • Mestecky J , RussellMW: Specific antibody activity, glycan heterogeneity and polyreactivity contribute to the protective activity of S-IgA at mucosal surfaces.Immunol. Lett.124(2) , 57–62 (2009).
  • Bos NA , BunJC, PopmaSHet al.: Monoclonal immunoglobulin A derived from peritoneal B cells is encoded by both germ line and somatically mutated VH genes and is reactive with commensal bacteria.Infect. Immun.64(2) , 616–623 (1996).
  • Dunn-Walters D , BoursierL, SpencerJ: Effect of somatic hypermutation on potential N-glycosylation sites in human immunoglobulin heavy chain variable regions.Mol. Immunol.37(3–4) , 107–113 (2000).
  • Schroten H , StapperC, PlogmannR, KöhlerH, HackreJ, HanischFG: Fab-independent antiadhesion effects of secretory immunoglobulin A on S-fimbriated Escherichia coli are mediated by sialyloligosaccharides.Infect. Immun.66(8) , 3971–3973 (1998).
  • Mantis NJ , Farrant,SA, MehtaS: Oligosaccharide side chains on human secretory IgA serve as receptors for ricin.J. Immunol.172(11) , 6838–6845 (2004).
  • Dallas SD , RolfeRD: Binding of Clostridium difficile toxin A to human milk secretory component.J. Med. Microbiol.47(10) , 879–888 (1998).
  • Langley R , WinesB, WilloughbyN, BasuI, ProftT, FraserJD: The staphylococcal superantigen-like protein 7 binds IgA and complement C5 and inhibits IgA-Fc α RI binding and serum killing of bacteria.J. Immunol.174(5) , 2926–2933 (2005).
  • Borén T , FalkP, RothKA, LarsonG, NormarkS: Attachment of Helicobacter pylori to human gastric epithelium mediated by blood group antigens.Science262(5141) , 1892–1895 (1993).
  • Falk P , RothKA, BorénT, WestblomTU, GordonJI, NormarkS: An in vitro adherence assay reveals that Helicobacter pylori exhibits cell lineage-specific tropism in the human gastric epithelium.Proc. Natl Acad. Sci. USA90(5) , 2035–2039 (1993).
  • Hammerschmidt S , TalaySR, BrandtzaegP, ChhatwalGS: SpsA, a novel pneumococcal surface protein with specific binding to secretory immunoglobulin A and secretory component.Mol. Microbiol.25(6) , 1113–1124 (1997).
  • Rosenow C , RyanP, WeiserJNet al.: Contribution of novel choline-binding proteins to adherence, colonization and immunogenicity of Streptococcus pneumoniae.Mol. Microbiol.25(5) , 819–829 (1997).
  • Lu L , LammME, LiH, CorthésyB, ZhangJR: The human polymeric immunoglobulin receptor binds to Streptococcus pneumoniae via domains 3 and 4.J. Biol. Chem.278(48) , 48178–48187 (2003).
  • Elm C , BraathenR, BergmannSet al.: Ectodomains 3 and 4 of human polymeric immunoglobulin receptor (hpIgR) mediate invasion of Streptococcus pneumoniae into the epithelium.J. Biol. Chem.279(8) , 6296–6304 (2004).
  • Hammerschmidt S , TilligMP, WolffS, VaermanJP, ChhatwalGS: Species-specific binding of human secretory component to SpsA protein of Streptococcus pneumoniae via a hexapeptide motif.Mol. Microbiol.36(3) , 726–736 (2000).
  • Luo R , MannB, LewisWSet al.: Solution structure of choline binding protein A, the major adhesin of Streptococcus pneumoniae.EMBO J.24(1) , 34–43 (2005).
  • Zhang JR , MostovKE, LammMEet al.: The polymeric immunoglobulin receptor translocates pneumococci across human nasopharyngeal epithelial cells.Cell102(6) , 827–837 (2000).
  • Brock SC , McGrawPA, WrightPF, CroweJE: The human polymeric immunoglobulin receptor facilitates invasion of epithelial cells by Streptococcus pneumoniae in a strain-specific and cell type-specific manner.Infect. Immun.70(9) , 5091–5095 (2002).
  • Kaetzel CS . Polymeric Ig receptor: defender of the fort or Trojan horse? Curr. Biol.11(1) , R35–R38 (2001).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.